Won Jun Choi Selected Research

Won Jun Choi Research Topics

Disease

10	Neoplasms (Cancer) 12/2023 - 09/2009
6	Acute Cholecystitis 12/2023 - 12/2021
5	Inflammation (Inflammations) 12/2022 - 07/2010
4	Stomach Neoplasms (Stomach Cancer) 09/2022 - 01/2008
3	Metabolic Diseases (Metabolic Disease) 01/2022 - 02/2020
3	Endometriosis 09/2020 - 09/2019
2	Pathologic Processes 12/2022 - 04/2014
2	COVID-19 03/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 06/2021 - 05/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 05/2020
2	Carcinogenesis 04/2018 - 07/2015
2	Neoplasm Metastasis (Metastasis) 07/2015 - 10/2013
2	Colorectal Neoplasms (Colorectal Cancer) 07/2014 - 10/2013
2	Colonic Neoplasms (Colon Cancer) 04/2014 - 05/2002
1	Carcinoma (Carcinomatosis) 12/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2022
1	Premature Obstetric Labor (Premature Labor) 12/2022
1	Gallbladder Diseases (Gall Bladder Disease) 09/2022
1	Infertility (Sterility) 03/2022
1	Fistula 01/2022
1	Vesicovaginal Fistula 01/2022
1	Hypersensitivity (Allergy) 11/2021
1	Atopic Dermatitis (Atopic Eczema) 09/2020
1	Hyperplasia 09/2020
1	Insulin Resistance 05/2020
1	Overweight 05/2020
1	Pelvic Organ Prolapse 01/2019
1	Hemorrhage 08/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2018
1	Papilloma (Papillomatosis) 04/2018
1	Demyelinating Diseases (Demyelinating Disease) 11/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2016
1	Globoid Cell Leukodystrophy (Krabbe Disease) 11/2016
1	Lymphoma (Lymphomas) 05/2016
1	Myoma 01/2016
1	Abdominal Pain (Pain, Abdominal) 01/2016
1	Vomiting 07/2014
1	Nausea 07/2014

Drug/Important Bio-Agent (IBA)

3	Vitamin D-Binding ProteinIBA 12/2022 - 09/2019
3	AdiponectinIBA 01/2022 - 02/2020
3	LigandsIBA 04/2014 - 07/2010
2	ErbB Receptors (EGF Receptor)IBA 12/2023 - 12/2022
2	human ERBB2 proteinIBA 12/2023 - 12/2022
2	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 05/2020
2	VaccinesIBA 03/2022 - 01/2021
2	Vitamin D FDA LinkGeneric 09/2020 - 09/2019
2	Biomarkers (Surrogate Marker)IBA 05/2020 - 04/2014
2	hydroxide ionIBA 09/2019 - 09/2019
1	N- (2- (4- ((3- chloro- 4- (3- (trifluoromethyl)phenoxy)phenyl)amino)- 5H- pyrrolo(3,2- d)pyrimidin- 5- yl)ethyl)- 3- hydroxy- 3- methylbutanamideIBA 12/2023
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2023
1	LipidsIBA 12/2022
1	COVID-19 VaccinesIBA 03/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2022
1	mRNA VaccinesIBA 03/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	galanginIBA 01/2022
1	Indigo Carmine (Indigo Blue)IBA 01/2022
1	CorticosteroneIBA 11/2021
1	Radioisotopes (Radionuclides)IBA 06/2021
1	oxidized low density lipoproteinIBA 03/2021
1	LDL Receptors (LDL Receptor)IBA 03/2021
1	LDL CholesterolIBA 03/2021
1	Proprotein Convertase 9IBA 03/2021
1	OxazoloneIBA 09/2020
1	cardamoninIBA 09/2020
1	CytokinesIBA 09/2020
1	LignansIBA 09/2020
1	diphenyl (biphenyl)IBA 09/2020
1	Insulin (Novolin)FDA Link 05/2020
1	MicroRNAs (MicroRNA)IBA 05/2020
1	marliolideIBA 04/2018
1	Heme Oxygenase-1IBA 04/2018
1	GalactosylceramidaseIBA 11/2016
1	EnzymesIBA 11/2016
1	Psychosine (Galactosylsphingosine)IBA 11/2016
1	lysyllysine (Lys-Lys)IBA 05/2016
1	Proteins (Proteins, Gene)FDA Link 05/2016
1	Lysine (L-Lysine)FDA Link 05/2016
1	maackiapterocarpan BIBA 01/2016
1	Keratins (Keratin)IBA 07/2015
1	Transcription Factors (Transcription Factor)IBA 07/2014
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 07/2014
1	ramosetron (Nasea)IBA 07/2014
1	Palonosetron (Aloxi)FDA Link 07/2014
1	Syndecan-1 (Syndecan 1)IBA 04/2014
1	Glucosylceramides (Glucocerebrosides)IBA 04/2014
1	GangliosidesIBA 04/2014
1	CDw17 antigen (lactosylceramide)IBA 04/2014
1	DisaccharidesIBA 04/2014

Therapy/Procedure

5	Laparoscopic Cholecystectomy 12/2023 - 12/2021
3	Cholecystectomy 09/2022 - 12/2021
3	Gastrectomy 09/2022 - 03/2011
3	Conservative Treatment 12/2021 - 05/2011
2	Drug Therapy (Chemotherapy) 07/2014 - 10/2013
1	Therapeutics 01/2021
1	Mediterranean Diet 05/2020
1	Operative Time 08/2018
1	Brachytherapy 04/2018
1	Radiotherapy 04/2018
1	Uterine Myomectomy 01/2016